Recalls / Active ingredient / Paroxetine Hydrochloride Hemihydrate
Paroxetine Hydrochloride Hemihydrate
3 FDA drug recalls involving the active ingredient “Paroxetine Hydrochloride Hemihydrate”.
| Date | Class | Product | Firm |
|---|---|---|---|
| 2017-11-20 | Class II | Paroxetine Tablets USP, 30 mg, a) 30 count (NDC 68382-099-06), b) 500 count (NDC 68382-099-05), and c) 1000 | Zydus Pharmaceuticals USA Inc |
| 2017-08-18 | Class II | Paroxetine tablets USP, 30mg, 30-count bottles, Rx Only, Manufactured by: Cadila Healthcare Ltd, Ahmedabad, In | Zydus Pharmaceuticals USA Inc |
| 2017-06-22 | Class III | Paroxetine Extended-Release Tablets USP, 12.5 mg, 30 count bottle, Rx only, Manufactured for: Lupin Pharmaceut | Lupin Pharmaceuticals Inc. |